<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37026945</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>14</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>07</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Severe varicella-zoster virus meningoencephalomyelitis coexisting with visceral disseminated varicella-zoster virus infection in a patient with lupus nephritis: A case report.</ArticleTitle><Pagination><StartPage>e33459</StartPage><MedlinePgn>e33459</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e33459</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000033459</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Meningoencephalomyelitis and visceral dissemination infection are rare but life-threatening complications of either the primary infection or reactivation of varicella-zoster virus (VZV) in immunocompromised patients. To date, few studies have reported the co-existence of VZV meningoencephalomyelitis and the visceral dissemination of VZV infection.</AbstractText><AbstractText Label="PATIENT CONCERNS" NlmCategory="METHODS">A 23-year-old male was diagnosed with lupus nephritis class III and was being treated with oral prednisone and tacrolimus. The patient exhibited herpes zoster 21-day after the initiation of therapy and experienced unbearable abdominal pain and generalized seizures 11 days after the onset of a zoster rash. Magnetic resonance imaging showed progressive lesions in the cerebrum, brainstem, and cerebellum, as well as meningeal thickening and thoracic myelitis. Computed tomography showed pulmonary interstitial infiltration, partial intestinal dilatation, and effusion. Metagenomic next-generation sequencing revealed 198,269 and 152,222 VZV-specific reads in the cerebrospinal fluid and bronchoalveolar lavage fluid, respectively.</AbstractText><AbstractText Label="DIAGNOSES" NlmCategory="METHODS">Based on the clinical and genetic findings, this patient was finally diagnosed with VZV meningoencephalomyelitis and visceral disseminated VZV infection.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">The patient received intravenous acyclovir (0.5&#x2009;g every 8 hours) combined with plasma exchange and intravenous immunoglobulin. Treatment against secondary bacterial and fungal infections, organ support therapy and rehabilitation training were given simultaneously.</AbstractText><AbstractText Label="OUTCOME" NlmCategory="RESULTS">The patient's peripheral muscle strength did not improve and repeated metagenomic next-generation sequencing showed the persistence of VZV-specific reads in the cerebrospinal fluid. The patient finally abandoned therapy due to financial constraints at the 1-month follow-up.</AbstractText><AbstractText Label="LESSONS" NlmCategory="CONCLUSIONS">Patients with autoimmune diseases receiving immunosuppressive therapy should be warned about the possibility of developing serious neurological infections and visceral disseminated VZV infections as side effects. Early diagnosis and the early initiation of intravenous acyclovir therapy are important for such cases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Kunlan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhi</LastName><ForeName>Lijia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Critical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Song</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shuqin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yuexian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Lizeyu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Liangbin</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2867-4915</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Peiyang</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Critical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4HES1O11F</RegistryNumber><NameOfSubstance UI="D000212">Acyclovir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014645" MajorTopicYN="N">Herpesvirus 3, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006562" MajorTopicYN="Y">Herpes Zoster</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073618" MajorTopicYN="Y">Varicella Zoster Virus Infection</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002644" MajorTopicYN="Y">Chickenpox</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000212" MajorTopicYN="N">Acyclovir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004679" MajorTopicYN="Y">Encephalomyelitis</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>This work was supported by the National Natural Science Foundation of China (No.81873298) and the Special Research Program of Sichuan Provincial Administration of Traditional Chinese Medicine (No.2021MS414). The authors have no conflicts of interest to disclose. The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>10</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37026945</ArticleId><ArticleId IdType="pmc">PMC10082274</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000033459</ArticleId><ArticleId IdType="pii">00005792-202304070-00046</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kennedy PG. Issues in the treatment of neurological conditions caused by reactivation of varicella zoster virus (VZV). Neurotherapeutics. 2016;13:509&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4965400</ArticleId><ArticleId IdType="pubmed">27032406</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy PGE, Gershon AA. Clinical features of varicella-zoster virus infection. Viruses. 2018;10:609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6266119</ArticleId><ArticleId IdType="pubmed">30400213</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Choi S, Kwon JS, et al. . Varicella zoster virus (VZV)-specific immunity and subclinical VZV reactivation in patients with autoimmune diseases. Korean J Intern Med. 2021;36:992&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8273822</ArticleId><ArticleId IdType="pubmed">34126665</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun H, Yang S, Chen L, et al. . Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination. Arthritis Rheumatol. 2016;68:2328&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5396838</ArticleId><ArticleId IdType="pubmed">26990731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy PG, Mogensen TH. Determinants of neurological syndromes caused by varicella zoster virus (VZV). J Neurovirol. 2020;26:482&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438298</ArticleId><ArticleId IdType="pubmed">32495195</ArticleId></ArticleIdList></Reference><Reference><Citation>Habuka M, Wada Y, Kurosawa Y, et al. . Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report. BMC Res Notes. 2018;11:165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5838883</ArticleId><ArticleId IdType="pubmed">29506558</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel MA, Niemeyer CS, Bubak AN. Central nervous system infections produced by varicella zoster virus. Curr Opin Infect Dis. 2020;33:273&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32332223</ArticleId></ArticleIdList></Reference><Reference><Citation>Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system &#x2013; Prognosis, diagnostics and treatment. J Infect. 2015;71:281&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">26073188</ArticleId></ArticleIdList></Reference><Reference><Citation>Corti M, Trione N, Villafa&#xf1;e MF, et al. . Acute meningoencephalomyelitis due to varicella-zoster virus in an AIDS patient: report of a case and review of the literature. Rev Soc Bras Med Trop. 2011;44:784&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22231256</ArticleId></ArticleIdList></Reference><Reference><Citation>McKelvie PA, Collins S, Thyagarajan D, et al. . Meningoencephalomyelitis with vasculitis due to varicella zoster virus: a case report and review of the literature. Pathology (Phila). 2002;34:88&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">11902456</ArticleId></ArticleIdList></Reference><Reference><Citation>Tascini C, Polidori M, Flammini S, et al. . Acute varicella-zoster virus necrotizing meningoencephalomyelitis with sudden visual loss and paraparesis in an HIV-infected patient. New Microbiol. 2010;33:267&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20954447</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratman E. Visceral zoster as the presenting feature of disseminated herpes zoster. J Am Acad Dermatol. 2002;46:771&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12004322</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama M, Yoshifuji K, Fukuda T, et al. . [Fulminant visceral disseminated varicella-zoster virus infection without skin involvement in a patient with autoimmune hemolytic anemia on prednisolone therapy]. Rinsho Ketsueki. 2016;57:467&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">27169452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattori K, Tanaka S, Ishikawa J, et al. . Visceral disseminated varicella zoster virus infection during non-intensive maintenance therapy in a patient with systemic lupus erythematosus. Mod Rheumatol Case Rep. 2022;7:57&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35781576</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuo Y, Igarashi Y, Aoyama N, et al. . Visceral disseminated varicella-zoster virus infection in an immunocompetent host. Clin J Gastroenterol. 2022;15:568&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">35235151</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Wang JQ, Tao XG. Fatal visceral disseminated varicella-zoster virus infection in a renal transplant recipient: a case report. World J Clin Cases. 2021;9:9168&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8567532</ArticleId><ArticleId IdType="pubmed">34786401</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader MS. Herpes zoster: diagnostic, therapeutic, and preventive approaches. Postgrad Med. 2013;125:78&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">24113666</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med. 2005;352:2266&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15930416</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty EF, Michaud K, Katz R, et al. . Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Lupus. 2013;22:238&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">23257402</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnann JW, Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002;186(Suppl 1):S91&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12353193</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan EL, Krigman MR. Herpes zoster myelitis. Evidence for viral invasion of spinal cord. Arch Neurol. 1973;29:309&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">4355263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung CH, Chang KH, Kuo HC, et al. . Features of varicella zoster virus myelitis and dependence on immune status. J Neurol Sci. 2012;318:19&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">22564884</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarczmann P. [The visceral manifestations of herpes zoster]. Munch Med Wochenschr. 1964;106:1033&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">14221312</ArticleId></ArticleIdList></Reference><Reference><Citation>Merayo-Chalico J, G&#xf3;mez-Mart&#xed;n D, Pi&#xf1;eir&#xfa;a-Men&#xe9;ndez A, et al. . Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study. QJM. 2013;106:451&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23458779</ArticleId></ArticleIdList></Reference><Reference><Citation>Persson A, Bergstr&#xf6;m T, Lindh M, et al. . Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels. J Clin Virol. 2009;46:249&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">19709927</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilden D, Cohrs RJ, Mahalingam R, et al. . Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009;8:731&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2814602</ArticleId><ArticleId IdType="pubmed">19608099</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang M, Aslam S. Varicella zoster virus encephalitis in solid organ transplant recipients: case series and review of literature. Transpl Infect Dis. 2019;21:e13038.</Citation><ArticleIdList><ArticleId IdType="pubmed">30548548</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinque P, Bossolasco S, Vago L, et al. . Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection? Clin Infect Dis. 1997;25:634&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9314452</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>